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OsteogenesisWnt signaling mediated by β-catenin has been implicated in early endocardial cushion development, but its
roles in later stages of heart valve maturation and homeostasis have not been identiﬁed. Multiple Wnt
ligands and pathway genes are differentially expressed during heart valve development. At E12.5, Wnt2 is
expressed in cushion mesenchyme, whereas Wnt4 and Wnt9b are predominant in overlying endothelial
cells. At E17.5, both Wnt3a and Wnt7b are expressed in the remodeling atrioventricular (AV) and semilunar
valves. In addition, the TOPGAL Wnt reporter transgene is active throughout the developing AV and
semilunar valves at E16.5, with more localized expression in the stratiﬁed valve leaﬂets after birth. In chicken
embryo aortic valves, genes characteristic of osteogenic cell lineages including periostin, osteonectin, and Id2
are expressed speciﬁcally in the collagen-rich ﬁbrosa layer at E14. Treatment of E14 aortic valve interstitial
cells (VICs) in culture with osteogenic media results in increased expression of multiple genes associated
with bone formation. Treatment of VIC with Wnt3a leads to nuclear localization of β-catenin and induction
of periostin and matrix gla protein but does not induce genes associated with later stages of osteogenesis.
Together, these studies provide evidence for Wnt signaling as a regulator of endocardial cushion maturation
as well as valve leaﬂet stratiﬁcation, homeostasis, and pathogenesis.
© 2009 Elsevier Inc. All rights reserved.Introduction
Developmental defects in atrioventricular and semilunar valves
are among the most common congenital heart malformations, and
aortic valve replacement is the second most common cardiac surgery
in the United States (Freeman and Otto, 2005; Hoffman and Kaplan,
2002; Pierpont et al., 2007). The majority of the aortic valves that are
replaced also have congenital malformations, establishing a link
between abnormal valve development and valve disease later in life
(Roberts and Ko, 2005). During vertebrate embryonic development,
the cardiac valves initially arise from endocardial cushions that form
in the atrioventricular (AV) canal and outﬂow tract (OFT) regions of
the primitive heart tube (Armstrong and Bischoff, 2004; Person et al.,
2005b). The endocardial cushions contribute to valve primordia that
subsequently elongate into the mature leaﬂets of the AV and
semilunar valves (Combs and Yutzey, 2009a). The mature valve
leaﬂets are stratiﬁed into ﬁbrosa, spongiosa, and atrialis/ventricularis
layers characterized by differential localization of extracellular matrix
(ECM) proteins with distinct mechanical properties (Aikawa et al.,
2006; Hinton et al., 2006). Heart valve disease is characterized by
disorganization of ECM proteins as well as cellular abnormalities that
contribute to dysfunction (Hinton et al., 2006; Rabkin et al., 2001;
Rabkin-Aikawa et al., 2004). There is increasing evidence thatutzey).
ll rights reserved.signaling pathways and transcription factors critical for valve
development also contribute to heart valve disease.
Wnt signaling has multiple functions at different stages of heart
development with demonstrated functions at the earliest stages of
cardiac myocyte lineage development during embryogenesis in vivo,
as well as in embryonic stem cells (Cohen et al., 2008; Kwon et al.,
2008; Tzahor, 2007). Manipulation of β-catenin expression in mice
has demonstrated a further requirement for Wnt signaling in cell
proliferation in the secondary heart ﬁeld and in epicardial develop-
ment (Grigoryan et al., 2008; Zamora et al., 2007). In the developing
valves, Wnt signaling has been implicated in the regulation of
endothelial-to-mesenchymal transition (EMT) and cell proliferation
during the initial stages of endocardial cushion formation in multiple
animal models (Hurlstone et al., 2003; Liebner et al., 2004; Person et
al., 2005a). Later functions for Wnt signaling in valve maturation and
homeostasis have not been reported. In adults, increased Wnt
pathway gene expression is associated with calciﬁc aortic valve
disease (Caira et al., 2006; Rajamannan et al., 2005). However, the
functions of Wnt signaling in valve development, homeostasis, and
pathogenesis are not well understood.
The regulatory mechanisms that control heart valve formation
share many molecular features with cartilage, tendon, and bone
development (Lincoln et al., 2006b). Previous studies have shown
extensive similarities in the molecular regulation of the valve leaﬂet
patterning and differentiation with regulatory hierarchies that control
cartilage and tendon development in both chicken and mouse
embryos (Levay et al., 2008; Lincoln et al., 2006a; Lincoln et al.,
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maturation of the ﬁbrosa layer, which has molecular and cellular
characteristics similar to undifferentiated osteoblasts and other
ﬁbroblast lineages (Chakraborty et al., 2008). Wnt signaling functions
at multiple stages during osteogenesis and also promotes ﬁbrosis in
multiple organ systems, consistent with a role in ﬁbrous connective
tissue development (He et al., 2009; Leucht et al., 2008; Morrisey,
2003). In adult human aortic valve sclerosis, the ﬁbrosa layer is the
primary site of valve calciﬁcation, further supporting parallels in valve
development and disease mechanisms with osteogenesis (Freeman
and Otto, 2005).
The expression and function of Wnt pathway genes and signaling
activation in valvulogenesis was examined in chicken and mouse
embryonic systems. Multiple Wnt pathway ligands, receptors, and
modifying proteins are differentially expressed in the endocardial
cushions and remodeling valves in both species. In addition, the
TOPGALWnt reporter is active throughout remodeling atrioventricular
(AV) and semilunar valves with restricted expression in the stratiﬁed
valves after birth inmice. The function ofWnt signaling in activation of
genes expressed in the stratiﬁed valves and preosteoblasts was
examined in primary cultures of chicken embryonic (E14) aortic
valve interstitial cells (VICs) that express ﬁbrosa layer markers.
Treatment of VICs with osteogenic media results in increased
expression of multiple genes associated with the early stages of
osteogenic differentiation. Treatment of VICs with Wnt3a leads to
induction of periostin (POSTN) and matrix gla protein (MGP) gene
expression, and Wnt signaling inhibition blocks induction of these
genes by osteogenic media. Together, these studies provide evidence
for canonical Wnt signaling as a regulator of heart valve lineage
maturation and pathogenesis.
Materials and methods
Mouse and chicken embryo collection
Wild-type FVBN mouse embryos were isolated at E12.5 or E17.5
after timed matings, with evidence of a copulation plug considered
E0.5. Whole E12.5 embryos or isolated E17.5 hearts were ﬁxed in 4%
paraformaldehyde before in situ hybridization as previously described
(Chakraborty et al., 2008; Lange and Yutzey, 2006). Alternatively,
E12.5 AV cushions or E17.5 AV valves were dissected, and RNA was
isolated as previously described (Chakraborty et al., 2008). Hearts
from transgenic TOPGAL Wnt reporter mice (DasGupta and Fuchs,
1999) were assayed for β-gal expression by X-gal staining in
histological sections as previously described (Lincoln et al., 2004).
Fertilized white leghorn chicken eggs (Charles River Laboratories)
were incubated at 38 °C under high humidity. Embryos were collected
at 14 days of incubation and hearts isolated in 1× phosphate-buffered
saline (PBS) for in situ hybridization or valve leaﬂet dissection as
previously described (Shelton and Yutzey, 2007; Shelton and Yutzey,
2008). All animal procedures were carried out using protocols
approved by Cincinnati Children's Medical Center Biohazard Safety
Committee and Institutional Animal Care and Use Committee.
Microarray analysis
RNA isolated from mouse E12.5 AV cushions or E17.5 AV valves
was ampliﬁed, biotin-labeled and hybridized in biological replicates
to Affymetrix Mouse Genome 430 2.0 arrays as previously described
(Chakraborty et al., 2008). The scanned gene expression data were
subjected to Robust Multichip Average (RMA) analysis, and gene
expression values for E12.5 AV cushions versus E17.5 AV valves were
calculated and subjected to statistical analysis as previously described.
A list of 3119 differentially expressed genes (N2.0 fold) was generated
and submitted to the GEO database (http://www.ncbi.nlm.gov/geo/)
with accession number GSE11040 (Chakraborty et al., 2008). Genesencoding proteins in the canonical and noncanonical Wnt pathways
were identiﬁed based on homology to characterized proteins (http://
www.stanford.edu/~rnusse/wntwindow.html (Cohen et al., 2008))
and a heat map of relative expression levels generated as previously
described (Chakraborty et al., 2008).
In situ hybridization
In situ hybridizations were performed on parafﬁn-embedded and
sectioned (14 μm) E12.5 mouse embryos, isolated mouse E17.5 hearts
or isolated chicken E14 hearts as previously described (Chakraborty et
al., 2008; Shelton and Yutzey, 2008; Somi et al., 2004). Sequences
corresponding to mouse Wnt2, Wnt4, Wnt3a, Wnt7b, Wnt9b, Lef1,
Fzd2, as well as chicken MGP, osteonectin, Id2, Wnt3a, and LRP5 were
ampliﬁed by RT–PCR from embryonic limb or heart RNA. Forward and
reverse primers, annealing temperatures, and ampliﬁed sequence
length are shown in Table 1. For each transcript, the ampliﬁed DNA
was subcloned into pGEM T-vector (Promega), and identity was
conﬁrmed by sequencing. Chicken POSTN sequence was ampliﬁed,
and probe was generated as described previously (Shelton and
Yutzey, 2008). Digoxigenin-labeled antisense RNA probes were
generated as previously described (Ehrman and Yutzey, 1999; Shelton
and Yutzey, 2007). Probes for mWnt3a, mWnt4, and mWnt7b were
synthesized with Sp6 polymerase from plasmids linearized with
Nco1. The probe for mWnt2 was synthesized with Sp6 polymerase
from plasmid linearized with SacII. Probes for cLRP5 and cMGP were
synthesized with T7 polymerase after linearization with Not1 or Nde1,
respectively.
Valve cell culture
Primary aortic valve interstitial cells (VICs) were isolated from
chicken embryos at E14 and cultured on collagen-coated chamber
slides. Aortic valve leaﬂets were explanted, dissected away from the
aorta with ﬁne forceps, and subjected to treatment with Collagenase II
(Worthington; 100 U/ml) in Hank's balanced salt solution (Cellgro) at
37 °C 3×7minutes in a shakingwater bath (Evans et al., 2003). Pooled
supernatants from 4 to 6 valves were spun at 800 rpm, and the cell
pellet was resuspended in 3 ml of complete M199 culture medium
containing 10% fetal bovine serum (Hyclone) plus penicillin/strepto-
mycin (Invitrogen). The cells were plated on collagen-coated 2-well
permanox chamber slides (Nunc) and cultured for 2–5 days. For
studies of osteogenic gene induction, the cells were treated with
complete media containing β-glycerophosphate (10 mM) and
ascorbic acid (50 μg/ml) (β-GP/AA) (Gerstenfeld and Landis, 1991).
Osteogenic mediumwas added after 3 days in culture and replenished
after an additional 2 days. Alternatively, osteogenesis was induced
using the Millipore stem cell osteogenesis kit (complete media with
10 mM β-glycerophosphate, 0.2 μM ascorbic acid, 0.1 μM dexameth-
asone) with similar results. For the analysis of canonical Wnt
signaling, isolated aortic VIC cultures were treated with recombinant
mouse Wnt3a protein (150 ng/ml; R&D Systems), the Wnt inhibitor
mouse sFRP3 (150 ng/ml; R&D Systems), or control vehicle BSA
(150 ng/ml) in the presence or absence of β-GP/AA osteogenicmedia.
After an additional 2 days, RNAwas isolated for qRT–PCR, or cells were
ﬁxed for immunostaining as previously described (Shelton and
Yutzey, 2007; 2008).
Immunostaining and confocal analysis
Smooth muscle α-actin (Sigma) immunostaining of parafﬁn-
embedded E12.5 embryo sections (7 μm) was performed as
previously described (Combs and Yutzey, 2009b). Cultured valve
cells were ﬁxed in cold 70% methanol for 20 min and preblocked in
PBS with 5% BSA for at least 1 hour. Antibodies used for immunostain-
ing include mouse monoclonal antibodies to unphosphorylated β-
Table 1
Oligonucleotide sequences of primers for PCR.
Gene Product
size
Annealing
temperature
(°C)
Sequence
(A) Primers for generation of antisense RNA probes
Mouse
Wnt2
NM_023653.4
831 62 5′-CTGGCTCTGGCTCCCTCTGCTCTT-3′
5′- GCCTGCCTCTCGGTCCCTGATACA-3′
Wnt3a
NM_009522.1
795 63 5′-AGCCACCCGGGAGTCAGCCTTTGT-3′
5′-GGAACCTTGCCCCTCGGAATGAAC-3′
Wnt4
NM_009523.1
776 62 5′-CGGAACCGGCGCTGGAACT-3′
5′-GCACTGCCGGCACTTGACGAA-3′
Wnt7b
NM_009528.2
844 63 5′-CAGCGGTGCAGGTGGAGGTGGTG-3′
5′-AGGGAGGGGCCGGGAGGAGTGAG-3′
Wnt9b
NM_011719
758 61 5′-AGGACTTGGGGCCGGAGAACAGAC-3′
5′-TGAGAGCAGGGGGTGGAAGCAGAC-3′
Lef1
NM_010703
639 62 5′-GCAGCGGAGCGGAGATTACACAGC-3′
5′-CCAACGCCGCCCGGAGACAGG-3′
Fzd2
NM_020510.2
878 64 5′-CGTCACGGCGCGGAGCAGAT-3′
5′-AAGCCGGCCAGCAGGAAGGATGTA-3′
Chicken
Osteonectin
NM_204410.1
608 58 5′-GCTGCAAGATGAGAACCTGGAT-3′
5′-GGCGCTTCTCATTCTCGTGGAT-3′
Id2
NM_205002.1
891 58 5′-ACTCCAAGCTGAAGGAGCTG-3′
5′-AAACGTCCATTTCTGCCACT-3′
MGP
NM_205044.1
615 60 5′-TACAGGCTGGCTGGGAAG-3′
5′-CAAACACCCACATCCTGAAC-3′
Wnt3a
NM_204675
782 60 5′-AAGTCGTTCTGCAGCGAAGT-3′
5′-AGCGCTGTCGTATTTGTCCT-3′
LRP5
NM_001012897
820 60 5′-TTGACGCGCATCTGAGGTGTAA-3′
5′-CCACACCTCGCAGCCAATACATG-3′
(B) Primers for qRT–PCR
Chicken
Periostin
NM_001030541
271 65 5′-GTGCTGTCCTGGCTACATGA-3′
5′-TGTGGTGGTGGAGAGCATTA-3′
MGP
NM_205044.1
615 60 5′-TACAGGCTGGCTGGGAAG-3′
5′-CAAACACCCACATCCTGAAC-3′
Runx2
NM_204128
211 65 5′-CCCCGGCTCCTCCCAAAACCAA-3′
5′-CCGCCTCCACACCGTCACTCTG-3′
Osteocalcin
NM_205387.1
175 60 5′-AGTGGAGCTGCACCATGAA-3′
5′-GCTGTCCTGGGCGTAGTG-3′
ALP
XM_423297
210 60 5′-GCGGCTGCAGCACCTCAACC-3′
5′-CGCGCTGTCGGGCACCTGT-3′
Fig. 1. Wnt pathway genes are differentially expressed in the developing AV valves at
E12.5 and E17.5. An Affymetrix microarray gene expression analysis was performed on
duplicate samples of RNA isolated from E12.5 AV cushions or E17.5 AV valves. The
presence of Wnt signaling pathway genes was determined among genes with N2.0-fold
statistically signiﬁcant change at E12.5 versus E17.5 (Chakraborty et al., 2008). A heat
map was generated of relative gene expression levels based on raw intensity values.
Red indicates increased expression, blue indicates decreased expression, and yellow
indicates no change in expression.
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collagen I (M38; Developmental Hybridoma Bank, IA; 1:100), collagen
VI (39; Developmental Hybridoma Bank, IA; 1:100), and rabbit
polyclonal antisera for periostin (Abcam; 1:200), ﬁbronectin (Dako
Cytomation; 1:200), and Id1/2 (Santa Cruz; 1:100). Primary anti-
bodies were incubated at indicated dilutions in PBS/blocking solution
(1% BSA, 0.1% cold water ﬁsh skin gelatin, 0.1% Tween-20, 0.05% NaN3)
at 4 °C overnight. Secondary antisera for immunoﬂuorescence
including Alexa goat anti-mouse-488, Alexa goat anti-rabbit-568 or
Alexa goat anti-rabbit-488 (Invitrogen) were used at 1:200 in PBS for
1 hour. ToPro3 iodide (Invitrogen) was used at (1:1000) in PBS for
nuclear labeling. Immunoﬂuorescence was detected using a Zeiss LSM
510 confocal microscope and images were captured using LSM
version 3.2 SP2 software.
Real-time qRT–PCR
RNA was isolated from valve cell cultures or dissected embryo
heart valves and used to generate cDNA as previously described
(Shelton and Yutzey, 2007). Quantitative real-time PCR (qRT–PCR)
was performed using primers in Table 1 with indicated annealing
temperatures and expected product size or as reported previously
(Shelton and Yutzey, 2007, 2008). The identity of each of the
ampliﬁed DNA fragments was conﬁrmed by sequencing. One
microgram of cDNA was used in qRT–PCR performed in triplicate as
previously reported (Shelton and Yutzey, 2007, 2008). Gene expres-sion levels were determined based on a threshold cycle of detection
for each ampliﬁed product relative to a standard curve of calibration
for each primer pair. Standard curves were generated with cDNA from
E8 chicken heart or E14 chicken wing, and all values were normalized
to GAPDH expression. Fold changes of gene expression were
calculated in triplicate for at least three independent experiments.
Statistical signiﬁcance of observed differences was calculated using
Student's t-test (pb0.05–0.01).
Results
Differential expression of Wnt pathway genes in mouse heart valve
development
Affymetrix microarray gene expression analysis was performed on
RNA isolated from mouse E12.5 AV cushions and E17.5 AV valves to
identify genes differentially expressed during early and late stages of
valvulogenesis (Chakraborty et al., 2008). A list of 3119 differentially
expressed genes (at least 2× difference) was generated that can be
accessed in the GEO database (GSE11040). Several identiﬁed genes in
the Wnt signaling pathway are among the differentially expressed
genes based on published pathways (Cohen et al., 2008; Nusse, 2005).
Differential expression of Wnt ligands, receptors, downstream
transcription factors, and modulating proteins was observed (Fig. 1;
Supplemental Table 1). Wnt signaling pathway genes elevated in the
E12.5 AV cushions relative to remodeling AV valves include Wnt2,
Wnt4, Wnt5b, Wnt9b, Lef1, Dvl2, Dkk1, and Fzd2. At later stages of
valvulogenesis, increased expression of Wnt inhibitors Wisp1 and
Wif1 was detected. Together these expression data provide evidence
for dynamic regulation of multiple components and regulators of Wnt
signaling at early and late stages of valvulogenesis.
The localized expression of selected Wnt pathway genes elevated
in mouse E12.5 AV cushions relative to E17.5 AV valves was examined
by in situ hybridization (Fig. 2). Wnt2 is expressed in the AV and OFT
cushionmesenchyme and endothelial cells but not in the adjacent OFT
myocardium (Figs. 2A and B; data not shown). Expression of the Wnt
receptor Frizzled 2 (Fzd2) and theWnt-responsive transcription factor
Lef1 also is apparent in the AV and OFT endocardial cushion
mesenchyme at E12.5, with little or no expression in the endocardial
endothelial cells (Figs. 2C–F). Lef1 expression is speciﬁc to the
endocardial cushions, whereas Frzd2 expression also is apparent in
myocardium and smooth muscle. In contrast, Wnt4 and Wnt9b are
expressed together speciﬁcally in endocardial endothelial cells
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and Wnt9b are not expressed in the endocardium of the atria or
ventricles, suggesting a speciﬁc role in endocardial endothelial
cushion development. Microarray expression analysis indicated that
each of these genes is downregulated in E17.5 remodeling AV valves
(Fig. 1), and loss of expression in E17.5 AV and OFT valves was
conﬁrmed by in situ hybridization (data not shown). Together, theseFig. 2.Wnt pathway genes are differentially expressed inmesenchymal and endothelial
cells of mouse E12.5 endocardial cushions. In situ hybridizations of sectioned hearts
show Wnt pathway gene expression in both atrioventricular canal (AVC; left panels)
and outﬂow tract (OFT; right panels) cushions at E12.5. The ligand Wnt2 (A, B),
receptor frizzled2 (Fzd2; C, D), and downstream transcription factor LEF1 (E, F) are
expressed in cushion mesenchyme (indicated by arrows). In contrast, the ligandsWnt4
(G, H) and Wnt9b (I, J) are expressed speciﬁcally in the cushion endothelial layer
(indicated by arrows). Antibody staining for smooth muscle α-actin (SMA) indicates
muscle cells (K, L). Endocardial cushions (EC), interventricular septum (IVS), and Aorta
(Ao) are indicated.studies support the presence ofWnt pathway activity through speciﬁc
ligands in endothelial and mesenchymal cells of the developing AV
and OFT endocardial cushions after initiation of EMT.
Wnt signaling status was examined in the remodeling valve
primordia of mouse embryos at E16.5 and in stratiﬁed valve leaﬂets
1 month after birth. Previous studies demonstrated active Wnt
signaling throughout the endocardial cushions of the AV canal at
E12.5 using TOPGAL transgenic mice that express β-galactosidase
where canonical Wnt signaling is active (DasGupta and Fuchs, 1999;
Gitler et al., 2003). TOPGALWnt reporter activity was assessed at later
stages in the remodeling valve leaﬂets by X-gal staining in histological
sections. At E16.5, TOPGAL reporter activity is predominant through-
out the AV and OFT valve leaﬂet primordia, indicating widespread
Wnt pathway activation in the remodeling valves (Figs. 3A and B). At
1 month after birth, TOPGAL activity is apparent in a subset of cells in
the stratiﬁed aortic and mitral valves, with predominant activity on
the ﬁbrosa side away from blood ﬂow (Figs. 3C and D). The
widespread activation of the TOPGAL reporter gene in the prenatal
valve primordia and restricted expression after birth are consistent
with a role for canonical Wnt signaling in remodeling, stratiﬁcation,
and homeostasis of the valve leaﬂets.
Expression of Wnt3a and Wnt7b was examined in the remodeling
valves at E17.5. These ligands were chosen based on their develop-
mental roles in ﬁbroblast and osteogenic cell lineages that share
molecular characteristics with the ﬁbrosa cell layer of the remodeling
AV and semilunar valves (Chakraborty et al., 2008; Derfoul et al.,
2004; Hu et al., 2005).WhileWnt ligandswith increased expression at
E17.5 were not initially identiﬁed in the valve developmental
expression screen, TOPGAL reporter gene activation indicates Wnt
pathway activity in the remodeling valve leaﬂets (Fig. 3). Expression
of bothWnt3a andWnt7bwas detected in the AV and semilunar valve
leaﬂets at E17.5 (Figs. 4A–D) and also in osteoblasts of the developing
bone (data not shown). In the developing mitral valve leaﬂets,Wnt3a
is predominant at the tips of the valves (Fig. 4A). Wnt7b is expressed
more highly on the ﬁbrosa surface, although there is some expression
on the atrialis side of the mitral valve leaﬂets (Fig. 4B). Expression of
Wnt3a is apparent in the aortic valve leaﬂets preferentially on the
ﬁbrosa side (Fig. 4B, arrows), whereas Wnt7a expression is detected
throughout the leaﬂets (Fig. 4D, arrows). Wnt3a and Wnt7b also are
expressed in the AV canal adjacent to the mitral valve (Figs. 4A and B,Fig. 3. The Wnt pathway is active in mouse mitral and aortic valves as indicated by
TOPGAL reporter expression. (A–D) Analysis of TOPGAL Wnt pathway reporter mice
demonstrates pathway activation in the mitral valve (MV) and tricuspid valve (TV)
primordia as well as the aortic valve (AoV) at E16.5 (A, B), as indicated by X-gal
staining. Localized TOPGAL activity is also apparent in MV and AoV leaﬂets 1 month
after birth (C, D), predominantly on the ﬁbrosa side (indicated by arrows). The
interventricular septum (IVS) is indicated.
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septum and ventricular myocardium. In the developing valves,
expression of Wnt3a and Wnt7b ligands overlaps with regions
where the Wnt pathway is active as indicated by TOPGAL reporter
mice.Fig. 5. ECM, osteogenic, and Wnt pathway genes are locally expressed during aortic
valve stratiﬁcation in chicken embryos. In situ hybridization of sectioned E14 chicken
embryo hearts shows expression of (A) osteonectin, (B) periostin, (C) id2, (D)matrix gla
protein (MGP), (E) Wnt3a, and (F) LRP5 in aortic valve cusps (arrows). Expression also
is apparent in the aorta (asterisks). The aortic valve annulus is indicated by arrowheads
in B.Localized expression of ECM, osteogenic, and Wnt pathway genes in
stratiﬁed E14 chicken aortic valves
The expression of genes associated with the valve ﬁbrosa layer,
preosteoblast/ﬁbroblast cell types, as well as Wnt signaling was
examined in E14 chicken embryo aortic valves (Fig. 5). The secreted
proteins periostin (POSTN) and matrix-gla protein (MGP) are highly
expressed in preosteoblast and ﬁbroblast lineages with the potential
to undergo ECM mineralization (Kruzynska-Frejtag et al., 2001;
Murshed et al., 2004). Periostin has a role in ﬁbrillar collagen
biosynthesis, whereas MGP inhibits calciﬁcation of ﬁbrous tissues
and osteogenic progenitors (Norris et al., 2007; Yagami et al., 1999).
POSTN and MGP expression is increased in the stratiﬁed valves
relative to endocardial cushions in both avian and mouse embryos
(data not shown (Chakraborty et al., 2008)). POSTN gene expression
is predominant in the ﬁbrosa layer of the E14 aortic valve cusp and
annulus (Fig. 5B). MGP expression is predominant at the base of the
aortic valve and also on the ﬁbrosa surface of the valve as well as in
the aorta (Fig. 5D). Osteonectin and Id2, associated with multiple
ﬁbroblast and preosteoblast lineages, are also predominantly
expressed in the ﬁbrosa layer of the E14 aortic valve (Figs. 5A and
C). Wnt3a and its coreceptor LRP5 have previously been implicated
in osteogenesis and vascular development (Kato et al., 2002; Zhou et
al., 2008). In the aortic valve, Wnt3a is expressed at the base of the
cusp and also on the ﬁbrosa surface (Fig. 5E). LRP5 is predominantly
expressed at the tips of the valves, and expression of both Wnt3a
and LRP5 is apparent in the aorta (Figs. 5E and F). Expression of
Wnt3a was also detected in the developing skeleton and in feather
buds as previously reported (Yue et al., 2006). Together, these
expression analyses demonstrate ﬁbrosa-restricted gene expression
and the presence of Wnt pathway genes in the avian E14 aortic valve
leaﬂets.Fig. 4.Wnt3a andWnt7b are expressed inmousemitral and aortic valves at E17.5. (A–D)
In situ hybridization of sectioned E17.5 mouse hearts demonstrates that Wnt3a (A, B)
andWnt7b (C, D) are expressed in the remodeling mitral (MV) and aortic (AoV) valves.
Wnt3a and Wnt7b expression in the AV valves is apparent at the tips of the leaﬂets
(indicated by arrows) and in the AV canal (indicated by asterisks).Wnt3a is expressed
preferentially on the ﬁbrosa side the aortic valve leaﬂets (arrows, B).Wnt7b expression
is apparent throughout the AoV leaﬂets (arrows, D). The interventricular septum (IVS)
and aorta (Ao) are indicated.Induction of osteogenic genes in chicken aortic valve interstitial cell
cultures is affected by Wnt signaling
A chicken embryonic valve cell culture system was devised to
examine regulatory mechanisms of valve cell lineage maturation as
well as pathogenic mechanisms. E14 chicken embryo aortic valves
were used for isolation of VICs for cell culture. At this stage, the valve
leaﬂets are stratiﬁed with osteonectin, POSTN, and Id2 expression
predominant in the ﬁbrosa layer (Figs. 5A–C). The expression of
proteins associated with ﬁbrosa layer was examined in isolated E14
aortic valve cells. After 5 days in culture, nearly all of the cells (∼90%)
express type 1 collagen (Hinton et al., 2006), Id1/2, POSTN, and
ﬁbronectin (FN) (Kruithof et al., 2007), characteristic of the ﬁbrosa
layer (Fig. 6). Widespread expression of smooth muscle α-actin
(SMA) is indicative of an activated myoﬁbroblast phenotype typical of
cultured VICs (Liu et al., 2007). Decreased expression of the
endothelial marker Tie2 was observed in cultured VICs relative to
intact aortic valves as detected by RT–PCR (data not shown).
Therefore the isolated E14 avian aortic VIC population after several
days in culture consists predominantly of cells with a ﬁbrosa-like
phenotype, as has been demonstrated for VICs isolated from adult
large animal models (Liu et al., 2007).
The ability to manipulate canonical Wnt signaling was assessed by
immunolocalization of β-catenin in avian E14 VICs in the presence of
increased or decreasedWnt signaling. Under normal culture conditions,
β-catenin protein expression is apparent in a subset of cells with
localization predominantly at the cell membrane (Fig. 7A). Treatment
with recombinant Wnt3a protein resulted in widespread stabilization,
as well as nuclear localization, of β-catenin protein apparent in 1 hour
(Fig. 7B). Inhibition of Wnt signaling was achieved with treatment of
cells with theWnt pathway antagonist soluble frizzled-related protein-
3 (sFRP3). In the sFRP3-treated cultures, decreased immunoreactivity
Fig. 6. Cultured E14 chicken aortic valve cells have a ﬁbrosa-like phenotype. Immunostaining and confocal analysis demonstrates expression of (A) collagen I, (B) collagen VI, (C)
ﬁbronectin (FN), (D) periostin (POSTN), (E) Id1/2, and (F) smooth muscle α-actin (SMA) in aortic valve cells cultured for 5 days. Indicated proteins are shown in green with the
exception of Id1/2, which is red. Nuclear staining of Id1/2 and distribution of SMA are indicated by arrows. Nuclei are stained blue with ToPro3.
132 C.M. Alﬁeri et al. / Developmental Biology 338 (2010) 127–135for β-catenin protein was observed relative to cells in normal growth
medium or in cells treated with Wnt3a ligand (Fig. 7C). These studies
demonstrate thatWnt signaling can bemanipulated in avian E14 aortic
valve interstitial cells with the predicted effects on β-catenin stability
and subcellular localization.
The potential of heart valve interstitial cells to activate an
osteogenic gene proﬁle was examined in isolated primary cell cultures
from chicken embryo day 14 aortic valve leaﬂets. For osteogenic gene
induction, E14 VICs were treated with osteogenic medium containing
β-glycerophosphate (10 mM) and ascorbic acid (50 μg/ml) (β-GP/
AA), which induces calciﬁcation of human VICs and promotes bone
mineralization in osteoblast cell cultures (Gerstenfeld and Landis,
1991; Mathieu et al., 2005). E14 VICs were also treated with
osteogenic medium containing dexamethasone with similar results
(data not shown). Several genes associated with ﬁbrous connective
tissues, osteogenesis, and valve calciﬁcation were examined in treated
VIC cultures. POSTN and MGP are expressed in preosteoblasts as well
as in multiple types of ﬁbroblasts and connective tissues capable of
undergoing calciﬁcation (Kruzynska-Frejtag et al., 2001; Murshed et
al., 2005; Takeshita et al., 1993). The transcription factor Runx2 is
expressed during the early stages of osteoblast differentiation and also
in human calciﬁed aortic valves (Karsenty andWagner, 2002; O'Brien,
2006; Rajamannan et al., 2003). Alkaline phosphatase (ALP) and os-
teocalcin (OCN) are markers of bone differentiation and also are
characteristic of human valve calciﬁcation (Karsenty and Wagner,
2002; Mathieu et al., 2005). Expression of genes associated withFig. 7. β-Catenin protein expression is increased in E14 Aortic VIC treated with Wnt3a but n
Wnt3a or (C) sFRP3 for 1 hour. Increased nuclear and cytoplasmic β-catenin protein (green
treated relative to control or sFRP3-treated cells. Nuclei (blue) were visualized using ToProosteogenesis and human aortic valve diseasewas examined in chicken
aortic VIC cultures by qRT–PCR using sequence-speciﬁc primers
shown in Table 1. In these experiments, POSTN and MGP are strongly
induced with β-GP/AA treatment. Runx2, OCN, and ALP expression
also is signiﬁcantly increased (Fig. 8A). These studies demonstrate
that avian E14 aortic valve interstitial cells treated with osteogenic
medium in culture have the potential to activate several genes
associated with bone lineage development and/or pathological
calciﬁcation of ﬁbrous connective tissues.
The effects of increased or decreased Wnt signaling on osteogenic
gene induction were examined in cultured E14 aortic VICs (Fig. 8B).
Treatment withWnt3a alone results in increased expression of POSTN
and MGP, both of which are expressed in preosteoblast lineages and
multiple types of ﬁbrous connective tissues as well as the developing
valves. In contrast, expression of Runx2, OCN, and ALP markers of
osteoblasts and differentiating bone was not induced by Wnt3a
treatment. Treatment with Wnt3a together with osteogenic medium
enhances induction of POSTN and MGP, with strong synergistic
induction of MGP (35-fold). However, addition of Wnt3a did not
augment the induction of Runx2, OCN, or ALP expression under
osteogenic conditions. Treatment of aortic VICs with osteogenic
medium in the presence of the Wnt antagonist sFRP3 blunted the
induction of POSTN and MGP but had no apparent effect on the
osteoblast lineage markers Runx2, OCN, and ALP. Overall these studies
demonstrate that Wnt signaling is necessary and sufﬁcient for
induction of POSTN and MGP, which are normally present in theot sFRP3. Primary E14 aortic VIC cultures were treated with (A) control vehicle BSA, (B)
) was detected by immunoﬂuorescence and confocal microscopy (arrows) in Wnt3a-
3.
Fig. 8. Induction of osteoblast-associated genes in avian E14 aortic VIC cultures treated
with β-glycerophosphate/ascorbic acid is enhanced by increased Wnt signaling. (A)
E14 embryonic aortic valve cells were cultured in the presence or absence of osteogenic
(osteo) media containing β-glycerophosphate (10 mM) and ascorbic acid (50 μg/ml).
Expression levels of periostin (POSTN), matrix gla protein (MGP), Runx2, osteocalcin
(OCN), and alkaline phosphatase (ALP) transcripts were determined by qRT-PCR in
untreated (white bars) and treated (black bars) VIC cultures. Control values were set to
1, and fold differences are shown with error bars representing SEM. Statistically
signiﬁcant increases in gene expression in induced cells (pb0.05) are indicated by
asterisks. Baseline levels of expression are POSTN (19.26), MGP (3710.23), Runx2
(957.22), OCN (10.90), and ALP (100.37) relative ﬂuorescence units. (B) Primary
chicken embryo (E14) aortic valve cells were cultured as in (A) with the addition of
groups treated with Wnt3a or the Wnt antagonist sFRP3. Expression levels of POSTN,
MGP, Runx2, OCN, and ALP transcripts were determined by qRT–PCR for all groups.
Control values were set to 1, and fold differences are shown for a representative
experiment. Note induction of MGP and POSTN in the presence of osteogenic media is
enhanced by Wnt3a and is inhibited by sFRP3 treatments.
133C.M. Alﬁeri et al. / Developmental Biology 338 (2010) 127–135stratifying aortic valve and other ﬁbrous connective tissues. However,
increased Wnt signaling alone is not sufﬁcient to promote the
complete osteogenic gene program in cultured aortic VICs.
Discussion
There is emerging evidence that Wnt signaling has multiple
complex roles in vertebrate heart valve formation, homeostasis, and
disease. In this study, we report differential expression of Wnt
ligands and pathway genes at early and late stages of valvulogenesis.
In the E12.5 endocardial cushions, Wnt2 is predominant in the
mesenchyme, whereas Wnt4 and Wnt9b are coexpressed in endo-
thelial cells. The Wnt signaling pathway is active in the late fetal as
well as postnatal valve leaﬂets, and expression of Wnt3a and Wnt7b
is apparent at E17.5. In adult aortic valves, canonical Wnt signaling
has been implicated in pathologic calciﬁcation that could be related
to its function in osteoblast lineage development (Caira et al., 2006;
Leucht et al., 2008; Rajamannan et al., 2005). Chicken E14 aortic VICs
express multiple proteins that characterize the ﬁbrosa layer of thestratiﬁed valves and also have the potential to activate genes
associated with early and late stages of osteogenesis. Increased
Wnt signaling in aortic VIC cultures leads to increased expression of
POSTN and MGP, which also are expressed preosteoblasts and other
connective tissues with the potential to calcify. However, Wnt
signaling alone is not sufﬁcient to induce genes associated with
osteoblast differentiation, consistent with the reported role of Wnt
signaling in osteoblast cell lineage determination and progenitor
expansion (Leucht et al., 2008). Together, these results support the
involvement of Wnt signaling through speciﬁc distinct ligands at
multiple stages of valve development as well as contributing to valve
homeostasis and pathogenesis.
Expression of multiple Wnt pathway genes in the endocardial
cushion mesenchyme and endothelial cells is consistent with
functions in EMT and valve progenitor cell proliferation. Endothelial
cell-speciﬁc loss of β-catenin inmice demonstrates thatWnt signaling
is required for EMT during endocardial cushion formation (Liebner et
al., 2004). Manipulation of the Wnt receptor Frzb and Wnt9a in avian
embryos demonstrated a role for Wnt signaling in promoting
mesenchymal cell proliferation in the AV cushions (Person et al.,
2005a). Likewise, activation of canonical Wnt signaling throughout
AV cushion mesenchyme is apparent in TOPGAL Wnt reporter gene
expression at E12.5 in mice (Gitler et al., 2003). Here, we report
similar mesenchymal expression of additional Wnt pathway genes
Wnt2 (Wnt2a), LEF1, and Fzd2 in mouse AV as well as OFT cushions
consistent with a role in mesenchymal cell proliferation. Wnt2 also is
required for cardiac lineage differentiation in embryonic stem cells,
but defects in heart development have not been reported for mice
lacking Wnt2 that exhibit neonatal lethality with placental defects
(Monkley et al., 1996; Wang et al., 2007). It has been proposed that
Wnt2b may compensate for Wnt2a in regulation of cardiac develop-
ment (Cohen et al., 2008), but further studies are necessary to
determine the speciﬁc functions of Wnt2/2a in cardiac lineage
development and endocardial cushion maturation.
The localized expression of Wnt9b and Wnt4 in the endothelial
cells speciﬁcally overlying the endocardial cushions has not previ-
ously been reported. In the developing kidney, these ligands also are
coexpressed in the ureteric bud and pretubular aggregates, where
Wnt9b regulates Wnt4 to promote mesenchymal to epithelial
transitions (Carroll et al., 2005). Wnt9b also has been implicated in
epicardial cell activation, consistent with emerging evidence for
common regulatory mechanisms in endocardial cushion maturation
and epicardial-derived cell lineage maturation (Merki et al., 2005;
Shelton and Yutzey, 2008). Unlike the developing kidney, both
endocardial cushion formation and epicardial cell activation require
an epithelial to mesenchymal transition, and the roles of Wnt9b or
Wnt4 in these cardiac structures are unknown. Mice lacking Wnt9b
die within 24 hours of birth, presumably due to kidney agenesis, and
mice lacking Wnt4 also are born with defective kidney and gonadal
development (Carroll et al., 2005; Stark et al., 1994; Vainio et al.,
1999). It is possible that mice lacking either Wnt9b or Wnt4 have
undetected cardiac defects. However, based on their expression
together in the endocardial cushion endothelial cells, loss of both may
be necessary to reveal their functions in the early stages of valve
development. Mice lacking both Wnt4 and Wnt9b have not yet been
described.
The expression of Wnt3a and Wnt7b ligands in the remodeling
valves is consistent with a role in valve stratiﬁcation. In developing
osteoblasts, which share many characteristics with the valve ﬁbrosa
layer, Wnt3a promotes osteoblast lineage commitment that can be
inhibited by sFRP1 in culture (Zhou et al., 2008). Likewise, Wnt7b has
been identiﬁed as a potential endogenous ligand important in
osteoblast lineage development, and it also functions in vascular
smooth muscle development (Hu et al., 2005; Shu et al., 2002). Wnt
pathway activation, as indicated by TOPGAL reporter activity, occurs
throughout the valve primordia, but then is localized in the valve
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1 month after birth. The expression of several ﬁbrosa layer markers
along with the TOPGAL reporter throughout the valve primordia,
followed by restriction to the ﬁbrosa layer at later stages of
stratiﬁcation, is consistent with a mechanism whereby the ﬁbrosa
phenotype is a default cell fate that is repressed on the ﬂow side of the
valve leaﬂet during stratiﬁcation. It is likely that hemodynamics and
shear stress contribute to the localization of Wnt pathway activation
and valve stratiﬁcation, but the regulatory hierarchies involved have
not yet been fully deﬁned.
The hallmark of the valve ﬁbrosa layer is extensive highly
organized type I collagen ﬁbers, and additional ECM proteins
characteristic of preosteoblasts and ﬁbroblasts, including ﬁbronectin,
osteonectin, and collagen III, are also preferentially localized to the
ﬁbrosa layer of the stratiﬁed valves (Hinton et al., 2006; Kruithof et al.,
2007). These proteins are also coexpressed in cultured osteoblasts and
other connective tissues with the potential to mineralize (Murshed et
al., 2005). In cultured aortic VIC, Wnt signaling is necessary and
sufﬁcient for induction of POSTN and MGP gene expression charac-
teristic of ﬁbrous connective tissue. Periostin was initially described as
an osteoblast-speciﬁc protein, but it is dynamically regulated in the
developing heart valves, as well as other collagen-rich connective
tissues, and has a putative role in collagen ﬁbrillogenesis (Kruzynska-
Frejtag et al., 2001; Norris et al., 2007; Snider et al., 2008). MGP also is
expressed in undifferentiated osteoblasts and is an inhibitor of
vascular and cartilage calciﬁcation (Barone et al., 1991; Luo et al.,
1997). MGP null mice exhibit spontaneous calciﬁcation of the arteries,
but no valve abnormalities were reported (Luo et al., 1997). MGP
expression in the E14 avian aortic valve is predominant in
proteoglycan-rich spongiosa region, which may be related to its
function in cartilaginous structures. However, a protective role for
MGP in preventing aortic valve calciﬁcation has not yet been
demonstrated.
Increased canonical Wnt signaling, evident in expression of the
Wnt receptor Lrp5 and stabilized β-catenin has been associated with
adult calciﬁc valve disease (Caira et al., 2006; Rajamannan et al.,
2005). In human aortic valve disease and mouse models of valve
calciﬁcation, increased expression of Runx2 (Cbfa-1), osteopontin, os-
teocalcin, and alkaline phosphatase, characteristic of mineralized
bone, is observed (Aikawa et al., 2007; Caira et al., 2006; Rajamannan
et al., 2003). In this study, expression of each of these genes is
increased in isolated embryonic VIC treated with osteogenic medium.
However, increased Wnt signaling is not sufﬁcient to induce a full
osteogenic response, which is consistent with Wnt pathway activa-
tion in developing valves and postnatal valves that do not normally
calcify. Similarly, osteogenic media induces multiple markers of bone
differentiation and calciﬁcation in primary calvarial cultures and
ﬁbroblast cell lines, whereas increased Wnt signaling promotes early
osteoblast progenitor lineage commitment and expansion but has an
inhibitory role in osteocyte differentiation (Leucht et al., 2008; Shi et
al., 2007; Zhou et al., 2008). Wnt signaling also has been implicated in
pathological ﬁbrosis of the lung and kidney (He et al., 2009; Morrisey,
2003), which could be related to a role in valve pathogenesis.
Therefore our data provide initial evidence that Wnt signaling could
contribute to valve pathogenesis through alterations in the ECM that
affects its susceptibility to calciﬁcation. However, the full calciﬁcation
response likely requires multiple stimuli that together contribute to
heart valve dysfunction and insufﬁciency.Acknowledgments
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